Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Buy
67
EMR Quote, Financials, Valuation and Earnings
Last price:
$135.51
Seasonality move
:
2.32%
Day range:
$134.40 - $136.17
52-week range:
$90.06 - $150.27
Dividend yield:
1.58%
P/E ratio:
33.49x
P/S ratio:
4.26x
P/B ratio:
3.75x
Volume:
1.8M
Avg. volume:
2.5M
1-year change:
9.33%
Market cap:
$76.1B
Revenue:
$18B
EPS (TTM):
$4.05
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $18.2B | $13.8B | $15.2B | $17.5B | $18B | |
| Revenue Growth (YoY) | 8.59% | -24.28% | 9.87% | 15.32% | 2.97% | |
| Cost of Revenues | $11B | $7.9B | $8.3B | $9.7B | $9.4B | |
| Gross Profit | $7.2B | $5.9B | $6.9B | $7.8B | $8.6B | |
| Gross Profit Margin | 39.59% | 42.95% | 45.5% | 44.58% | 47.91% | |
| R&D Expenses | $485M | $385M | $523M | $781M | $771M | |
| Selling, General & Admin | $4.2B | $3.6B | $4.2B | $5.1B | $5.1B | |
| Other Inc / (Exp) | -$42M | $270M | $137M | -$557M | -- | |
| Operating Expenses | $4.2B | $3.6B | $4.2B | $5.1B | $5.1B | |
| Operating Income | $3B | $2.3B | $2.7B | $2.7B | $3.5B | |
| Net Interest Expenses | $166M | $228M | $261M | $323M | $387M | |
| EBT. Incl. Unusual Items | $2.9B | $2.4B | $2.7B | $2B | $2.9B | |
| Earnings of Discontinued Ops. | -- | $1.3B | $11.1B | $350M | $8M | |
| Income Tax Expense | $585M | $549M | $599M | $415M | $696M | |
| Net Income to Company | $2.3B | $3.2B | $13.2B | $2B | $2.2B | |
| Minority Interest in Earnings | $24M | -$1M | -$25M | -$13M | -$47M | |
| Net Income to Common Excl Extra Items | $2.3B | $1.9B | $2.1B | $1.6B | $2.2B | |
| Basic EPS (Cont. Ops) | $3.85 | $4.63 | $3.75 | $3.44 | $4.07 | |
| Diluted EPS (Cont. Ops) | $3.83 | $4.60 | $3.73 | $3.43 | $4.05 | |
| Weighted Average Basic Share | $598.1M | $592.9M | $574.2M | $571.3M | $564M | |
| Weighted Average Diluted Share | $601.8M | $596.3M | $577.3M | $574M | $566.7M | |
| EBITDA | $4B | $3.2B | $3.8B | $4.3B | $5B | |
| EBIT | $3B | $2.3B | $2.7B | $2.7B | $3.5B | |
| Revenue (Reported) | $18.2B | $13.8B | $15.2B | $17.5B | $18B | |
| Operating Income (Reported) | $3B | $2.3B | $2.7B | $2.7B | $3.5B | |
| Operating Income (Adjusted) | $3B | $2.3B | $2.7B | $2.7B | $3.5B | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $4.9B | $3.9B | $4.1B | $4.6B | $4.9B | |
| Revenue Growth (YoY) | 8.51% | -21.27% | 5.06% | 12.91% | 5.11% | |
| Cost of Revenues | $3B | $2.2B | $2.2B | $2.5B | $2.5B | |
| Gross Profit | $1.9B | $1.7B | $1.9B | $2.1B | $2.3B | |
| Gross Profit Margin | 38.54% | 43.61% | 46.03% | 45.55% | 47.62% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $1.1B | $983M | $1.1B | $1.3B | $1.3B | |
| Other Inc / (Exp) | -$22M | -$60M | $139M | -$93M | -- | |
| Operating Expenses | $1.1B | $983M | $1.1B | $1.3B | $1.3B | |
| Operating Income | $852M | $715M | $769M | $789M | $982M | |
| Net Interest Expenses | $42M | $70M | $54M | $79M | $122M | |
| EBT. Incl. Unusual Items | $828M | $603M | $904M | $679M | $796M | |
| Earnings of Discontinued Ops. | -- | $255M | $37M | $438M | $1M | |
| Income Tax Expense | $154M | $150M | $209M | $149M | $160M | |
| Net Income to Company | $674M | $708M | $738M | $968M | $637M | |
| Minority Interest in Earnings | $4M | -$32M | -$6M | -$28M | -- | |
| Net Income to Common Excl Extra Items | $674M | $453M | $695M | $530M | $636M | |
| Basic EPS (Cont. Ops) | $1.12 | $0.82 | $1.23 | $1.74 | $1.13 | |
| Diluted EPS (Cont. Ops) | $1.12 | $0.82 | $1.22 | $1.74 | $1.13 | |
| Weighted Average Basic Share | $595.8M | $591.4M | $572M | $572.4M | $562.8M | |
| Weighted Average Diluted Share | $600.5M | $594.5M | $574.7M | $573.9M | $565.5M | |
| EBITDA | $1.1B | $986M | $1B | $1.2B | $1.4B | |
| EBIT | $852M | $715M | $769M | $789M | $982M | |
| Revenue (Reported) | $4.9B | $3.9B | $4.1B | $4.6B | $4.9B | |
| Operating Income (Reported) | $852M | $715M | $769M | $789M | $982M | |
| Operating Income (Adjusted) | $852M | $715M | $769M | $789M | $982M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $18.2B | $13.8B | $15.2B | $17.5B | $18B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $11B | $7.9B | $8.3B | $9.7B | $9.4B | |
| Gross Profit | $7.2B | $5.9B | $6.9B | $7.8B | $8.6B | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $4.2B | $3.6B | $4.2B | $5.1B | $5.1B | |
| Other Inc / (Exp) | -$42M | $244M | $137M | -$557M | -- | |
| Operating Expenses | $4.2B | $3.6B | $4.2B | $5.1B | $5.1B | |
| Operating Income | $3.1B | $2.3B | $2.7B | $2.7B | $3.5B | |
| Net Interest Expenses | $166M | $228M | $261M | $341M | $386M | |
| EBT. Incl. Unusual Items | $2.9B | $2.4B | $2.8B | $2B | $2.9B | |
| Earnings of Discontinued Ops. | -- | $1.3B | $11B | $350M | $7M | |
| Income Tax Expense | $585M | $549M | $609M | $415M | $695M | |
| Net Income to Company | $2.3B | $3.2B | $13.2B | $2B | $2.2B | |
| Minority Interest in Earnings | $24M | -$1M | -$19M | -$13M | -$47M | |
| Net Income to Common Excl Extra Items | $2.3B | $1.9B | $2.2B | $1.6B | $2.2B | |
| Basic EPS (Cont. Ops) | $3.85 | $3.18 | $3.84 | $3.44 | $4.06 | |
| Diluted EPS (Cont. Ops) | $3.83 | $3.16 | $3.82 | $3.43 | $4.05 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | $4B | $3.2B | $3.8B | $4.4B | $5B | |
| EBIT | $3.1B | $2.3B | $2.7B | $2.7B | $3.5B | |
| Revenue (Reported) | $18.2B | $13.8B | $15.2B | $17.5B | $18B | |
| Operating Income (Reported) | $3.1B | $2.3B | $2.7B | $2.7B | $3.5B | |
| Operating Income (Adjusted) | $3.1B | $2.3B | $2.7B | $2.7B | $3.5B | |
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2026-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $13.8B | $15.2B | $17.5B | $18B | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $7.9B | $8.3B | $9.7B | $9.4B | -- | |
| Gross Profit | $5.9B | $6.9B | $7.8B | $8.6B | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $3.6B | $4.2B | $5.1B | $5.1B | -- | |
| Other Inc / (Exp) | $244M | $137M | -$557M | -$267M | -- | |
| Operating Expenses | $3.6B | $4.2B | $5.1B | $5.1B | -- | |
| Operating Income | $2.3B | $2.7B | $2.7B | $3.5B | -- | |
| Net Interest Expenses | $228M | $261M | $341M | $386M | -- | |
| EBT. Incl. Unusual Items | $2.4B | $2.8B | $2B | $2.9B | -- | |
| Earnings of Discontinued Ops. | $1.3B | $11B | $350M | $7M | -- | |
| Income Tax Expense | $549M | $609M | $415M | $695M | -- | |
| Net Income to Company | $3.2B | $13.2B | $2B | $2.2B | -- | |
| Minority Interest in Earnings | -$1M | -$19M | -$13M | -$47M | -- | |
| Net Income to Common Excl Extra Items | $1.9B | $2.2B | $1.6B | $2.2B | -- | |
| Basic EPS (Cont. Ops) | $3.18 | $3.84 | $3.44 | $4.06 | -- | |
| Diluted EPS (Cont. Ops) | $3.16 | $3.82 | $3.43 | $4.05 | -- | |
| Weighted Average Basic Share | $2.4B | $2.3B | $2.3B | $2.3B | -- | |
| Weighted Average Diluted Share | $2.4B | $2.3B | $2.3B | $2.3B | -- | |
| EBITDA | $3.2B | $3.8B | $4.4B | $5B | -- | |
| EBIT | $2.3B | $2.7B | $2.7B | $3.5B | -- | |
| Revenue (Reported) | $13.8B | $15.2B | $17.5B | $18B | -- | |
| Operating Income (Reported) | $2.3B | $2.7B | $2.7B | $3.5B | -- | |
| Operating Income (Adjusted) | $2.3B | $2.7B | $2.7B | $3.5B | -- | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $2.4B | $1.8B | $8.1B | $3.6B | $1.5B | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $3.5B | $2.3B | $2.5B | $2.9B | $3.1B | |
| Inventory | $2.1B | $1.7B | $2B | $2.2B | $2.2B | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $1.1B | $1.3B | $1.2B | $1.5B | -- | |
| Total Current Assets | $8.4B | $8.5B | $13.8B | $10.2B | $8.6B | |
| Property Plant And Equipment | $4.3B | $2.7B | $2.9B | $3.5B | $3.5B | |
| Long-Term Investments | $115M | $496M | $3.9B | $556M | $676M | |
| Goodwill | $7.7B | $13.9B | $14.5B | $18.1B | -- | |
| Other Intangibles | $2.9B | $6.6B | $6.3B | $10.4B | -- | |
| Other Long-Term Assets | $1.9B | $4.4B | $2.6B | $2.7B | -- | |
| Total Assets | $24.7B | $35.7B | $42.7B | $44.2B | $42B | |
| Accounts Payable | $2.1B | $1.3B | $1.3B | $1.3B | $1.4B | |
| Accrued Expenses | $3.3B | $3B | $3.2B | $3.9B | -- | |
| Current Portion Of Long-Term Debt | $538M | $516M | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | $1.3B | -- | -- | -- | |
| Total Current Liabilities | $6.2B | $7.8B | $5B | $5.7B | $9.8B | |
| Long-Term Debt | $6.2B | $8.6B | $8B | $7.7B | $8.8B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $14.8B | $19.4B | $16.1B | $16.7B | $21.7B | |
| Common Stock | $477M | $477M | $477M | $477M | $477M | |
| Other Common Equity Adj | -- | -$1.5B | -$1.3B | -$868M | -- | |
| Common Equity | $9.9B | $10.4B | $20.7B | $21.6B | $20.3B | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $40M | $6B | $5.9B | $5.9B | $16M | |
| Total Equity | $9.9B | $16.3B | $26.6B | $27.5B | $20.3B | |
| Total Liabilities and Equity | $24.7B | $35.7B | $42.7B | $44.2B | $42B | |
| Cash and Short Terms | $2.4B | $1.8B | $8.1B | $3.6B | $1.5B | |
| Total Debt | $6.7B | $9.1B | $8.6B | $8.2B | $9.4B | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $2.4B | $1.8B | $8.1B | $3.6B | $1.5B | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $3.5B | $2.3B | $2.5B | $2.9B | $3.1B | |
| Inventory | $2.1B | $1.7B | $2B | $2.2B | $2.2B | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $1.1B | $1.3B | $1.2B | $1.5B | -- | |
| Total Current Assets | $8.4B | $8.5B | $13.8B | $10.2B | $8.6B | |
| Property Plant And Equipment | $4.3B | $2.7B | $2.9B | $3.5B | $3.5B | |
| Long-Term Investments | $115M | $496M | $3.9B | $556M | $676M | |
| Goodwill | $7.7B | $13.9B | $14.5B | $18.1B | -- | |
| Other Intangibles | $2.9B | $6.6B | $6.3B | $10.4B | -- | |
| Other Long-Term Assets | $1.9B | $4.4B | $2.6B | $2.7B | -- | |
| Total Assets | $24.7B | $35.7B | $42.7B | $44.2B | $42B | |
| Accounts Payable | $2.1B | $1.3B | $1.3B | $1.3B | $1.4B | |
| Accrued Expenses | $3.3B | $3B | $3.2B | $3.9B | -- | |
| Current Portion Of Long-Term Debt | $538M | $516M | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | $1.3B | -- | -- | -- | |
| Total Current Liabilities | $6.2B | $7.8B | $5B | $5.7B | $9.8B | |
| Long-Term Debt | $6.2B | $8.6B | $8B | $7.7B | $8.8B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $14.8B | $19.4B | $16.1B | $16.7B | $21.7B | |
| Common Stock | $477M | $477M | $477M | $477M | $477M | |
| Other Common Equity Adj | -- | -$1.5B | -$1.3B | -$868M | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $40M | $6B | $5.9B | $5.9B | $16M | |
| Total Equity | $9.9B | $16.3B | $26.6B | $27.5B | $20.3B | |
| Total Liabilities and Equity | $24.7B | $35.7B | $42.7B | $44.2B | $42B | |
| Cash and Short Terms | $2.4B | $1.8B | $8.1B | $3.6B | $1.5B | |
| Total Debt | $6.7B | $9.1B | $8.6B | $8.2B | $9.4B | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $2.3B | $3.2B | $13.2B | $2B | $2.2B | |
| Depreciation & Amoritzation | $969M | $842M | $1.1B | $1.7B | $1.5B | |
| Stock-Based Compensation | $224M | $125M | $250M | $260M | $263M | |
| Change in Accounts Receivable | -$165M | -$143M | -$191M | -$99M | -$171M | |
| Change in Inventories | -$126M | -$334M | -$160M | $122M | -$1M | |
| Cash From Operations | $3.6B | $2.9B | $637M | $3.3B | $3.1B | |
| Capital Expenditures | $581M | $299M | $363M | $419M | $431M | |
| Cash Acquisitions | $1.6B | $5.7B | $705M | $8.3B | $7.3B | |
| Cash From Investing | -$2.1B | -$5.3B | $12.4B | -$5.4B | -$7.8B | |
| Dividends Paid (Ex Special Dividend) | $1.2B | $1.2B | $1.2B | $1.2B | $1.2B | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $71M | $5.4B | $395M | $322M | -- | |
| Long-Term Debt Repaid | -$883M | -$1.7B | -$3.6B | -$889M | -- | |
| Repurchase of Common Stock | $500M | $500M | $2.2B | $643M | $1.2B | |
| Other Financing Activities | $100M | $80M | -$169M | -$44M | -- | |
| Cash From Financing | -$2.4B | $2B | -$6.8B | -$2.5B | $2.7B | |
| Beginning Cash (CF) | $2.4B | $1.8B | $8.1B | $3.6B | $1.5B | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$961M | -$550M | $6.2B | -$4.5B | -$2B | |
| Ending Cash (CF) | $1.4B | $1.1B | $14.3B | -$855M | -$539M | |
| Levered Free Cash Flow | $3B | $2.6B | $274M | $2.9B | $2.7B | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $674M | $708M | $738M | $968M | $637M | |
| Depreciation & Amoritzation | $249M | $271M | $271M | $426M | $379M | |
| Stock-Based Compensation | $33M | $34M | $52M | $57M | $65M | |
| Change in Accounts Receivable | -$241M | -$174M | -$77M | -$143M | -$190M | |
| Change in Inventories | $34M | $19M | $99M | $156M | $90M | |
| Cash From Operations | $855M | $1.2B | -$643M | $1.1B | $1B | |
| Capital Expenditures | $231M | $100M | $169M | $168M | $168M | |
| Cash Acquisitions | -- | $87M | $705M | -- | $1M | |
| Cash From Investing | -$212M | -$359M | -$685M | $3.2B | -$200M | |
| Dividends Paid (Ex Special Dividend) | $301M | $305M | $298M | $300M | $297M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -$31M | -$392M | -- | -$2.2B | -- | |
| Long-Term Debt Repaid | -$578M | -$730M | -$99M | -$242M | -- | |
| Repurchase of Common Stock | $232M | $82M | $114M | $280M | $96M | |
| Other Financing Activities | $11M | -- | -$10M | $13M | -- | |
| Cash From Financing | -$1.1B | -$1.5B | -$521M | -$3B | -$1.5B | |
| Beginning Cash (CF) | $2.4B | $1.8B | $8.1B | $3.6B | $1.5B | |
| Foreign Exchange Rate Adjustment | -$18M | -$74M | -$57M | $40M | $6M | |
| Additions / Reductions | -$506M | -$725M | -$1.9B | $1.3B | -$675M | |
| Ending Cash (CF) | $1.8B | $1B | $6.1B | $4.9B | $875M | |
| Levered Free Cash Flow | $624M | $1.1B | -$812M | $916M | $842M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $2.3B | $3.2B | $13.2B | $2B | $2.2B | |
| Depreciation & Amoritzation | $969M | $842M | $1.1B | $1.7B | $1.5B | |
| Stock-Based Compensation | $224M | $125M | $250M | $260M | $263M | |
| Change in Accounts Receivable | -$165M | -$143M | -$191M | -$99M | -$171M | |
| Change in Inventories | -$126M | -$334M | -$160M | $122M | -$1M | |
| Cash From Operations | $3.6B | $2.9B | $637M | $3.3B | $3.1B | |
| Capital Expenditures | $581M | $299M | $363M | $419M | $431M | |
| Cash Acquisitions | $1.6B | $5.7B | $705M | $8.3B | $7.3B | |
| Cash From Investing | -$2.1B | -$5.3B | $12.4B | -$5.4B | -$7.8B | |
| Dividends Paid (Ex Special Dividend) | $1.2B | $1.2B | $1.2B | $1.2B | $1.2B | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $71M | $5.4B | -- | -- | -- | |
| Long-Term Debt Repaid | -$883M | -$1.7B | -$3.6B | -- | -- | |
| Repurchase of Common Stock | $500M | $500M | $2.2B | $643M | $1.2B | |
| Other Financing Activities | $100M | $80M | -$169M | -$44M | -- | |
| Cash From Financing | -$2.4B | $2B | -$6.8B | -$2.5B | $2.7B | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$961M | -$550M | $6.2B | -$4.5B | -$2B | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $3B | $2.6B | $274M | $2.9B | $2.7B | |
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2026-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $3.2B | $13.2B | $2B | $2.2B | -- | |
| Depreciation & Amoritzation | $842M | $1.1B | $1.7B | $1.5B | -- | |
| Stock-Based Compensation | $125M | $250M | $260M | $263M | -- | |
| Change in Accounts Receivable | -$143M | -$191M | -$99M | -$171M | -- | |
| Change in Inventories | -$334M | -$160M | $122M | -$1M | -- | |
| Cash From Operations | $2.9B | $637M | $3.3B | $3.1B | -- | |
| Capital Expenditures | $299M | $363M | $419M | $431M | -- | |
| Cash Acquisitions | $5.7B | $705M | $8.3B | $7.3B | -- | |
| Cash From Investing | -$5.3B | $12.4B | -$5.4B | -$7.8B | -- | |
| Dividends Paid (Ex Special Dividend) | $1.2B | $1.2B | $1.2B | $1.2B | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $5.4B | $395M | $322M | $8.3B | -- | |
| Long-Term Debt Repaid | -$1.7B | -$3.6B | -$889M | -$1.9B | -- | |
| Repurchase of Common Stock | $500M | $2.2B | $643M | $1.2B | -- | |
| Other Financing Activities | $80M | -$169M | -$44M | -$7.4B | -- | |
| Cash From Financing | $2B | -$6.8B | -$2.5B | $2.7B | -- | |
| Beginning Cash (CF) | $16B | $22.3B | $10.3B | $8.5B | -- | |
| Foreign Exchange Rate Adjustment | -$186M | $18M | $20M | -$39M | -- | |
| Additions / Reductions | -$550M | $6.2B | -$4.5B | -$2B | -- | |
| Ending Cash (CF) | $15.3B | $28.6B | $5.8B | $6.4B | -- | |
| Levered Free Cash Flow | $2.6B | $274M | $2.9B | $2.7B | -- | |
Get EMR Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
EMR
Sector
P/E ratio
33.49x
19.24x
PEG ratio
1.86x
0.18x
P/B ratio
3.75x
1.70x
Price / LTM sales
4.26x
0.85x
Growth Metrics
EMR
Sector
Revenue growth
5.11%
5.02%
Earnings growth
-35.1%
5.77%
Revenue (5-year growth)
1.41%
4.27%
Earnings forecast
$1.62
$0.39
Profitability
EMR
Sector
Profitability FY 2025
$8.6B
$253.7M
Return on invested capital
6.45%
4.73%
Return on assets
5.25%
3.1%
Return on equity
9.88%
8.11%
Earnings Date
Last Earnings Date
Nov
5
Next Earnings Date
Feb
4
Estimated Next Earnings Date
Feb
4
Balance Sheet
EMR
Sector
Total cash
$1.5B
$139M
Short term investments
--
$32.7M
Total assets
$42B
$1.4B
Long term debt
$9.4B
$51.5M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Is Bloom Energy The Best Stock to Buy Now?
Shares of energy startup Bloom Energy (NYSE:BE) have advanced by…
Stock Ideas
Buy
55
Is NVDA Stock a Buy?
Market Cap: $4.5T
P/E Ratio: 63x
Buy
53
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 36x
Buy
59
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
60
AAOI alert for Dec 23
Applied Optoelectronics, Inc. [AAOI] is up 3.95% over the past day.
Buy
60
ZBIO alert for Dec 23
Zenas BioPharma, Inc. [ZBIO] is up 1.18% over the past day.
Buy
54
UNF alert for Dec 23
UniFirst Corp. [UNF] is up 0.77% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
